VISCERAL FAT INDEX INFORMS RISK OF MEDICALLY REFRACTORY IBD AND NEED FOR SURGERY IN PATIENTS STARTING ANTI-TUMOR NECROSIS FACTOR (TNF) THERAPY

被引：0
|
作者：
Gu, Phillip
Chhabra, Avneesh
Chhittajallu, Punya
Chang, Christopher
Mendez, Denisse
Gilman, Andrew
Fudman, David
Xi, Yin
Feagins, Linda
机构：
来源：
INFLAMMATORY BOWEL DISEASES | 2021年 / 27卷
关键词：
D O I：
10.1093/ibd/izaa347.112
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S47 / S47
页数：1
相关论文
共 50 条
  • [31] Association of persistence with anti-tumor necrosis factor (anti-TNF) therapy and healthcare costs in patients with psoriatic arthritis (PSA)
    Tang, Boxiong
    Meissner, B.
    Dabbous, Omar
    Rahman, Mirza
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) : AB122 - AB122
  • [32] Effect of anti-tumor necrosis factor therapy on insulin resistance and body fat composition in rheumatoid arthritis patients
    Talaverano, S.
    Ferraz-Amaro, I. A.
    Luna, C.
    Quevedo, J. C.
    Rivero, B.
    Aznar, I.
    Muñiz, J.
    Lopez-Fernandez, J.
    Diaz-Gonzalez, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 351 - 351
  • [33] Erythromelalgia Secondary to Anti-Tumor Necrosis Factor (TNF) Alpha Therapy: A Report of Two Cases
    El Rhaoussi, Fatima Zahra
    Boukhal, Zineb
    Haddad, Fouad
    Tahiri, Mohamed
    Hliwa, Wafaa
    Bellabah, Ahmed
    Wafaa, Badre
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [34] Anti-tumor necrosis factor a therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis
    Schneeweiss, Sebastian
    Setoguchi, Soko
    Weinblatt, Michael E.
    Katz, Jeffrey N.
    Avorn, Jerry
    Sax, Paul E.
    Levin, Raisa
    Solomon, Daniel H.
    ARTHRITIS AND RHEUMATISM, 2007, 56 (06): : 1754 - 1764
  • [35] Anti-tumor necrosis factor therapy in children with refractory Takayasu arteritis: report of five cases
    YO Kostina
    GA Lyskina
    GM Rabieva
    EV Uspenskaya
    Pediatric Rheumatology, 9 (Suppl 1)
  • [36] Anti-tumor necrosis factor therapy with infliximab decreases the risk of stroke in patients with rheumatoid arthritis.
    Wolfe, F
    Nadareishvili, ZG
    Hallenbeck, JM
    Michaud, K
    ARTHRITIS AND RHEUMATISM, 2004, 50 (12): : 4099 - 4099
  • [37] Predictors of Switching Anti-Tumor Necrosis Factor Therapy in Patients with Ankylosing Spondylitis
    Lee, Jeong-Won
    Kang, Ji-Hyoun
    Yim, Yi-Rang
    Kim, Ji-Eun
    Wen, Lihui
    Lee, Kyung-Eun
    Park, Dong-Jin
    Kim, Tae-Jong
    Park, Yong-Wook
    Lee, Shin-Seok
    PLOS ONE, 2015, 10 (07):
  • [38] Mycobacterial Disease in Patients Who Use Anti-Tumor Necrosis Factor Therapy
    Winthrop, Kevin L.
    Baxter, Roger
    Liu, Liyan
    McFarland, Bentson
    Austin, Donald F.
    Varley, Cara D.
    Radcliffe, LeAnn
    Suhler, Eric B.
    Choi, Dongseok
    Rosenbaum, James T.
    Herrinton, Lisa J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S86 - S86
  • [39] Genotoxicity of Anti-Tumor Necrosis Factor Therapy in Patients With Juvenile Idiopathic Arthritis
    Demirkaya, Erkan
    Cok, Ismet
    Durmaz, Emre
    Ulutas, Onur K.
    Ayaz, Nuray Aktay
    Besbas, Nesrin
    Ozen, Seza
    ARTHRITIS CARE & RESEARCH, 2010, 62 (01) : 73 - 77
  • [40] Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis
    Hoffman, GS
    Merkel, PA
    Brasington, RD
    Lenschow, DJ
    Liang, P
    ARTHRITIS AND RHEUMATISM, 2004, 50 (07): : 2296 - 2304
12345